Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01900314 · ClinicalTrials.gov registry record · NA
Imaging Biomarkers for TMS Treatment of Depression
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01900314 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 40 participants.
The verdict
NCT01900314, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this research is to learn more about how rTMS works to reduce the symptoms of depression. This information can be used to improve the effectiveness of the treatment. The study will use functional magnetic resonance imaging (fMRI) to examine changes in brain function after treatment with rTMS. fMRI is a safe and painless technique that allows investigators to observe the brain "at work." The investigators will use fMRI to see what regions of the brain become active when you perform a concentration task and how that activation is changed after rTMS.
Interventions
- DEVICE repetitive Transcranial Magnetic Stimulation (rTMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01900314
The ClinicalTrials.gov registry entry for NCT01900314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.
NCT01900314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01900314 about?
NCT01900314 is a clinical study titled "Imaging Biomarkers for TMS Treatment of Depression". The purpose of this research is to learn more about how rTMS works to reduce the symptoms of depression. This information can be used to improve the effectiveness of the treatment. The study will use functional magnetic resonance imaging (fMRI) to examine changes in brain function after treatment wi...
What is the current status of trial NCT01900314?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-09. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01900314?
The interventions under investigation include: repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE).
Who is sponsoring clinical trial NCT01900314?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.